The use of expression microarrays to determine bona fide changes in gene expression between experimental paradigms is confounded by noise due to variability in measurement. To assess the variability associated with transcript hybridization to commercial oligonucleotide-based microarrays, we generated a data set consisting of five replicate hybridizations of a single labeled cRNA target from three distinct experimental paradigms, using the Affymetrix human U95 GeneChip set. We found that the variability of expression level in our data set is intensityspecific. We quantified the observed variability in our data set in order to determine significant changes in gene expression. LOESS fitting to a plot of the standard deviation of replicates assigned a variability associated with a specific intensity. This allowed for the calculation of a "variable fold-change" threshold for any absolute intensity at any level of statistical confidence. Testing of this method indicates that it removes intensity-specific bias and results in a 5-to 10-fold reduction in the number of false-positive changes. We suggest that this approach can be widely used to improve prediction of significant changes in gene expression for oligonucleotidebased microarray experiments and reduce false leads, even in the absence of replicates.
When searching for a set of differentially expressed genes among biological samples, most investigators choose an arbitrary threshold of difference in expression level. It is clear, however, that this threshold depends on the experimental precision, which is subject to biological and technological variability. Initial methods for interpretation of changes in expression microarray data used a simple fold-change statistic (1) . This method is subject to significant error rates, which can be considerably reduced by costly replicates of experiments. However, there are significant statistical limitations to the analysis of replicate data. For instance, multiple pair-wise comparison of replicate experiments by using a simple fold-change threshold is a significant improvement, but it is still subject to unacceptable error rates (2) . Classical statistical methods (e.g., t test) applied to replicates of expression microarray data are subject to significant error rates as well. In addition, many replicate experiments can be prohibitively costly and may not be practical for most investigators. Recently, statistical methods (such as SAM, SMA, and LUT scoring) have been devised that use replicate data sets to determine significant changes in signal intensity (2-4) (5).
In this study, we focused on technical variation and surmised that precision, reflecting the common processes of target hybridization, scanning, and analysis, depends on signal intensity. Arguably, a low-intensity signal would exhibit a greater absolute variance than signals at high intensity. If true, this would indicate that the threshold utilized to define a significant difference in gene expression depends on signal intensity. We present here the analysis of a data set containing five replicates for each of three experimental conditions for the entire Affymetrix U95 chipset interrogating 60,000 human-expressed sequences. The data were generated by parallel hybridization from three cRNA targets, each derived from an independent culture condition of primary human trophoblast cells. We used this unique data set to thoroughly analyze the variability of the oligonucleotide-based microarray technology. By characterizing the variance within groups of replicates, we were able to devise a method to determine significant changes in intensity at any given expression level within a single experiment. This statistical method provides an improved approach for identifying genes exhibiting changes in expression between conditions.
MATERIALS AND METHODS

Cell culture
Our study was approved by the human studies committee at Washington University School of Medicine, St. Louis, MO. Primary human trophoblasts were prepared from three normal-term human placentas, using the trypsin-DNAse-Dispase/Percoll method as described by Kliman et al. (6) with previously published modifications (7). Cultures were plated in 10-cm plates at a density of 300,000 cells/cm 2 and maintained in Earl's medium 199 (M199) containing 10% fetal bovine serum (Hyclone, Logan, UT) with antibiotics as previously described (8) . Four hours after plating, the medium was replaced with fresh medium supplemented by the PPARγ ligands troglitazone (10 µM) (Biomol, Plymouth Meeting, PA) or GW7845 (1 µM) (Glaxo-Wellcome, Research Triangle Park, NC), or by dimethyl sulfoxide vehicle control. Fresh media and ligands were added after 24 h in culture. After 48 h, the cells were collected for RNA.
RNA extraction and sample preparation
Total RNA was isolated using Tri-reagent (MRC, Cincinnati, OH) and purified using Qiagen's (Valencia, CA) RNeasy. RNA samples (30 µg) from three placentas were mixed, and the mixture was used for double-stranded cDNA synthesis, using Superscript Choice system (Gibco BRL, Carlsbad, CA) and a T 7 T 21 oligonucleotide primer (GenSet, La Jolla, CA). Biotin-labeled aRNA was synthesized by in vitro transcription, using Enzo Bioarray RNA labeling kit (Enzo Diagnostics, Farmingdale, NY). The RNA was fragmented and divided to five identical aliquots (15 µg of cRNA per aliquot). Each of the five cRNA aliquots was added to hybridization cocktail and sequentially to identical lot number U95A, U95B, U95C, U95D, and U95E arrays. All arrays were hybridized, washed, stained, and scanned using standard Affymetrix protocols.
Statistical analysis
Average difference value (ADV) was calculated using Affymetrix MAS 4.0 software. Total chip intensities were scaled to an average of 1500 units yielding scaled ADV (SADV). We obtained data regarding signal variability from five replicates for all 63,174 genes (~12,500 genes for each of the five chips) for each of the three paradigms, for a total of 189,522 sets of five data point replicates. All comparisons for variability were made within replicates.
Scatter plots of the standard deviation vs. means of intensity values showed a strong, but nonlinear, trend. To derive an estimate of the standard deviation in SADVs for a particular intensity, we applied a scatter plot smoothing technique called LOESS. For this purpose, we used the proc LOESS command in SAS. For a given value x of the independent variable, LOESS predicts the value at x by robust weighted regression, using data points in a local window whose size is determined by a specified smoothing parameter (9) . Data points within the window are weighted depending on their distance to x and the value of the smoothing parameter. Based on repeated trials and tests of general cross validation, we used a smoothing parameter of 0.3.
For a particular gene g, with observed expression levels x and y on chips X and Y, we define the score statistic of relative difference in expression for g by
where f (z) gives the predicted value of the standard deviation corresponding to observed mean intensity value of x and y derived from the LOESS fitting above. Under the assumption of normality, P values were assigned to a difference in x and y via the t score.
For analysis in MAS 5.0, total chip intensities were scaled to an average intensity of 1500, with manufacturer-defined parameters. Probe sets were identified as "outliers" if they showed a signal log ratio (SLR) ≥ 1 or ≤ -1 in more than six of the possible ten possible pair-wise comparisons within replicates of each experimental condition. The SLR is the new statistical metric that describes magnitude and direction of change in expression in this version of Affymetrix analysis software.
RESULTS
In an effort to comprehensively define the regulatory effects of PPARγ on differentiation of human trophoblasts (8, 10-12), we cultured primary-term human trophoblasts in the presence or absence of two different PPARγ ligands, troglitazone and GW7845, and examined alteration in gene expression between the paradigms. To examine the influence of expression microarray signal intensity on signal precision, we performed five complete replicate experiments from a single labeled cRNA target for each experimental condition. We examined the expression of known genes and expressed sequence tags in the five replicates, using Affymetrix's human GeneChips U95A-E. Thus, we obtained data regarding signal variability from five replicates for ∼62,500 genes ∼12,500 genes for each of the five chips) for each of the three paradigms, for a total of ∼187,500 sets of five data point replicates.
Identification of outliers
To examine the reproducibility of the data, we initially identified data points in our replicate experiments that represent the highest variability in the data set. Using the five replicates for each of the three experimental conditions, we defined an outlier as a gene with poor replicate reproducibility (greater than twofold change in expression in more than six of the ten possible pair-wise comparisons) within a condition. As shown in Figure 1 , the percentage of outliers was between 7.9 and 9.7% of all probe sets, depending on the treatment condition analyzed. The percentage of outliers was between 6.9 and 10.8% for all conditions, depending on the individual chip analyzed. We investigated the intensity-specific distribution of outlier occurrence at a defined intensity range. The distribution of outliers was strongly biased toward low signal intensity values (SADV). This was expected, because the distribution of intensities is also biased. However, the rate of the outliers (number of outliers relative to the total number of genes "expressed" at that defined intensity range) was also significantly biased toward low signal intensity values.
Transcripts that exhibit the highest variability among replicates (defined as outliers) and therefore most likely to lead to false-positive and -negative results, are disproportionate to signal intensity. To further explore the relationship between variability and intensity, we plotted the variability in fold-change within replicates relative to intensity (Fig. 2) . The mean fold-change in the ten pair-wise comparisons within each of the three conditions was calculated and graphed for each gene as a function of gene-specific mean intensity. This gave a total of 30 replicate foldchanges for each gene. We calculated a true fold-change by applying Affymetrix's fold-change algorithm, without adding or subtracting 1 from the result. As shown in Figure 2 , each gene is represented as three data points, one for each condition. These data demonstrate three points. First, replicate fold-change is inversely proportional to intensity. This is not entirely surprising, because fold-change is more susceptible to smaller absolute changes at lower signal intensities. Second, replicate variability is much higher than commonly used thresholds (2.0-3.0) at low intensity and lower than commonly used thresholds at high intensity. For Chip A, 12% of genes had a mean fold-change >2.0 at an SADV of <1000, whereas 100% of genes had a mean foldchange of <2.0 at an SADV of >30,000. Three, variability, as measured by replicate fold-change, is chip-specific.
Using intensity-specific variance to generate a variable fold-change threshold
We demonstrated that replicate variability is increased at low signal intensity and reduced at high signal intensity. This could clearly adversely affect the determination of bona fide changes in gene expression. To overcome this problem, we devised a method to utilize intensity-specific variability to determine significant changes in gene expression. The standard deviation of replicate intensities was calculated and plotted relative to mean intensity, giving a measure of intensity-specific variance that was assumed to be gene-independent (Fig. 3A) . A LOESS curve was fit to these data and used to estimate the variance at any given intensity. This strategy was initially applied on each chip (U95A-E) independently, because the variability for each chip was distinct. In addition, we calculated the variance by using the entire data set, generating a chipindependent estimate. The LOESS curve enabled us to assign confidence (P value) to an intensity-specific fold-change (as described in Materials and Methods), allowing the calculation of a variable fold-change threshold for any baseline intensity (ADV) at any given P value. Thus, for any pair of absolute expression values (x,y) we were able to calculate a fold change and pvalue. As described in Methods, we defined a p-value at an arbitrary confidence level and constructed a function, which demonstrates the dependence of significant fold changes on absolute baseline intensity. The data in Figure 3B depict fold-change thresholds as a function of absolute intensity, with a given P value of 0.05 and 0.01. Also note that a similar LOESS curve was independently obtained under each of the three conditions (Fig. 3C) . Combined with the outlier data presented in Figure 1 , these data indicate that variability was not introduced by combining data from the different experimental conditions. Additional analyses of the variability and a "differential expression" calculator based on our variable fold-change threshold are available as supplementary material (http://lungtranscriptome.bwh.harvard.edu).
Testing the variable fold-change threshold method
To confirm the validity of our approach to address replicate variability, we applied our strategy to the data presented in Figure 1 , which utilized the static fold-change threshold. Within the five replicates for each of the three experimental conditions, we identified an outlier as a gene with a P value <0.05 in more than six of the ten possible pair-wise comparisons. As shown in Figure 4 , the percentage of outliers was dramatically reduced to between 1.0 and 1.3% of all probe sets. Critically, the rate of outliers was distributed relatively uniformly across intensities, thereby diminishing intensity-specific bias.
Following completion of this study, Affymetrix released a newer version of analysis software (MAS 5.0). To compare this new software with our variable fold-change method, we analyzed the outlier rate and intensity bias present in MAS 5.0 intensities, using the output from reanalyzing the image (.dat) files with MAS 5.0. For the comparison, we used the SLR, the new metric describing magnitude and direction of expression changes, as a surrogate for fold-change. Within the five replicates for each of the three experimental conditions, we identified an outlier as described in Materials and Methods. The percentage of outliers was modestly reduced when compared with the MAS 4.0 fold-change to an average of 6.4% for all probe sets (Fig. 5) . Critically, the outliers retained an intensity-specific bias similar to that shown for MAS 4.0 (Fig.  1) . The variable fold-change threshold (Fig. 4) shows superior false-positive detection rate and removal of intensity-specific bias in determining differential expression.
DISCUSSION
The use of expression microarrays is widespread, but determining the meaningful portion of the abundant data generated from this technology when applied to a discriminate task (e.g., determining differences in two samples) is difficult. Diverse sources of variability, including the biological condition, RNA isolation, target generation, fabrication of microarray, hybridization, and analysis methods, affect the reliability of expression microarray data and limit validity of conclusions drawn from these experiments. In this study, we focused on technical components downstream from sample isolation and labeling and inherent in the protocol and the process of the hardware, which should be universally consistent for noncompetitive, oligonucleotide-based microarrays. We have quantified the technical variability and applied these data to increase confidence in determining bona fide changes in gene expression. Not only did we find that the technical variability was intensity-specific ( Fig. 1 and 2 ), but we developed a unique strategy to assess this variability and apply it to improve our prediction of changes in gene expression (Fig.  3) . As anticipated, this reveals that standard thresholds (e.g., 2.0 fold-change) are not stringent enough at low intensities. Surprisingly, it also reveals that standard thresholds are too stringent at high intensities. Our variable fold-change method successfully accommodates nonuniform variability at different intensities (Fig. 4) . Finally, we repeated our analysis with intensity data generated using MAS 5.0 (Fig. 5 ) and found that this newer version of analysis software retains a high false-positive error rate and intensity-specific bias, both of which are significantly minimized by the variable fold-change threshold.
In MAS 4.0, Affymetrix has applied a strategy to incorporate an estimation of noise into their fold-change calculation. We have used their approach and their algorithms in this study for consistency. In Figure 2 , we excluded the (+1/-1) adjustment to the data. However, in Figure 3B , we included the Affymetrix adjustment for direct translation of these results to other data sets derived from Affymetrix data analysis software. The use of Affymetrix algorithms and noise estimation does have profound effects on our results, as shown in Figure 3 and in Figure 1 . In Figure 3B , an inversion in the fold-change threshold occurs at very low positive SADVs. This inversion occurs at approximately the intensity of the estimated noise (Q), due to the replacement of low values with Q in the algorithm. For similar reasons, in Figure 1 , the number of outliers in the first positive SADV bin is disproportionately low. The appropriate conclusion is that the application of this strategy (as well as similar fold-change strategies) is subject to misinterpretation at SADV values below Q. Therefore, we suggest avoiding conclusions based on baseline intensities below Q.
The LOESS approach was previously used by Yang et al. (13) for normalization of expression data generated by spotted cDNA arrays to remove print-tip effects. Herein, we apply the LOESS fitting to derive a realistic prediction of the variability of a particular observed intensity level. Predicted values of standard deviation are used to construct a score statistic of relative difference in gene expression. The assumption of normality of data is implicit and essential only in calculating P values from the defined t statistic. When normality is violated, the calculated values of the statistic can be used to rank genes that are most likely to be differentially expressed.
Others have recently applied methods accommodating variable thresholds to expression microarray data. Tsien et al. (14) used a general strategy similar to ours, developing a masking technique in order to filter out replicate noise in low-density cDNA microarrays. But, the method cannot be directly applied to experiments with more than two microarrays. Butte et al. (3) used a similar strategy based on the variability of fold-change calculations between replicates. However, it is unclear whether this latter method completely accommodates intensity-specific bias. Mills and Gordon (4) used a large data set of replicate measurements to generate an intensity-specific matrix for weighting the accuracy of changes in gene expression. This method, based on absolute variability across experimental systems, laboratories, and animal strains, may not accurately reflect this inherent technical variability in a highly controlled single experiment.
Note that these methods require calculations of fold-changes between two observations. When more than two samples are available, it may be more powerful to maintain independence of data by refraining from fold-change calculations (such as in our defined t statistic) or by applying additional statistical tests to the data. Long et. al. (15) used a Bayesian approach to account for both intensity-specific and gene-specific variability in estimating true differences in gene expression. Applied to low-density nylon cDNA microarrays, this approach performed better than simple fold-change statistic or t test, with a slightly elevated false-positive rate for a small number of replicates. Although this approach is theoretically similar to ours, low-density nylon cDNA microarrays are likely to have different variability characteristics compared with the highdensity oligonucleotide-based microarrays used in our study. This would make the application of some statistical methods inappropriate (e.g., those presented in refs 5 and 15). Tusher et al. (2) used a method that calculates a gene-specific variance by using repeated measurements and that scores changes between conditions by using a t test with the gene-specific variance. This intriguing method significantly reduces false-discovery rates. However, the independent contribution of gene-specific effects and intensity-specific effects to expression microarray data variability is not clear at this time. Although probe-specific contributions to variability (or probedependent variability) certainly exist, they do not negate our intensity-specific approach.
We have shown that our variable fold-change method can accommodate variability at different intensities and therefore improve our confidence in genes predicted as changed in expression by using oligonucleotide-based microarrays. This method should be applicable even in the absence of replicates, to help define bona fide changes in gene expression between samples using data presented here and tools available on our Web site (http://lungtranscriptome.bwh.harvard.edu). The relative similarity in the variable fold-change thresholds between platforms (supplemental data), relative to other methods such as a static fold-change threshold, suggests that this method could be applicable to expression data generated from similar high-density oligonucleotide-based microarrays. Although we believe this represents a valuable incorporation and application of the technical variability in the determination of differential expression, many components of potential (e.g., biological, RNA quality) variability are not addressed by this study. The derivation and application of additional statistical noise models are clearly warranted. Furthermore, we fully advocate applying multiple analysis methods to a single data set in order to buttress conclusions. Proof that our variable fold-change threshold method is biologically relevant, as evidenced by consistency with results from classical measures of gene expression (e.g., Northern blot, real-time polymerase chain reaction) is the subject of current investigation. replicates for all conditions were identified as outliers if they showed a greater than twofold change in expression in at least 7 of the 10 possible pair-wise comparisons. Outliers are analogous to false-positives because they would be scored as differentially expressed even though they represent replicate measurements. Top: The total number of outliers (inset) and the number of outliers relative to the total number of genes "expressed" at a defined intensity range are presented. Bottom:
The number and percentage of replicate (within condition) outliers for each experimental condition and each chip in the U95 set are also shown. probe set within replicates was calculated using all 10 possible pair-wise comparisons for each of the three conditions. The mean fold-change in the 10 pair-wise comparisons within each of the three conditions was calculated and graphed for each gene as a function of gene-specific mean intensity. We calculated a true fold-change by applying Affymetrix's foldchange algorithm, without adding or subtracting 1 from the result. Three data points are plotted for each probe set, representing the mean fold-change within each of the three experimental conditions: control, troglitazone-treated, and GW7845-treated. Data for each of the five chips representing the U95 chip set are presented individually, revealing chipspecific variability in replicate fold-change. in intensity of replicates, quantified using standard deviation, was plotted relative to the mean intensity of each probe set for each condition. A LOESS curve was fit to the data and used to calculate the intensity-specific variance (A). LOESS curves were generated for each individual chip in the set to accommodate potential interchip variability (see Fig. 2 ). Using the LOESS curves, we calculated the change in intensity and then the fold-change necessary to provide 95% and 99% confidence that intensity values are significantly different (B). Only values for positive ADVs are presented. To measure the independent contribution of each experimental condition to the variability, a LOESS curve was also fit to all probe sets under each individual culture condition seperately (C). threshold, we identified outliers representing the probe sets with the highest replicate variability. Outliers were defined as described. Top: The number (inset) and rate of outliers was binned according to the mean intensity for the probe set in each condition. Bottom: The number and percentage of replicate (within condition) outliers for each experimental condition and each chip in the U95 set are also shown. replicates using intensity readings generated by MAS 5.0 are described. Probe sets were identified as outliers if they showed a SLR greater than or equal to an absolute value of 1, in at least 7 of the 10 possible pair-wise comparisons. Top: The total number of outliers (inset) and the number of outliers relative to the total number of genes "expressed" at a defined intensity range are presented. Bottom: The number and percentage of replicate (within condition) outliers for each experimental condition and each chip in the U95 set are also shown.
